BioSpace News Archive

Policy

Chinese Government Arrests GenScript and Legend Biotech Founder for Smuggling

Two months after he was stepped down from the role of chief executive officer of Legend Biotech, Fangliang “Frank” Zhang has been arrested for smuggling genetic resources from the People’s Republic of China.

November 24, 2020
·
3 min read
·
Alex Keown
FDA

Treating the Untreatable, FDA Greenlights First-Ever PH1 Treatment Oxlumo

The U.S. FDA approved Alnylam Pharmaceuticals’ Oxlumo (lumasiran) for primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in children and adults.

November 24, 2020
·
3 min read
·
Mark Terry
Job Trends

Eyeing the Future, Novartis Plans for Growth with Share Buyback

To support its long-term goals, the Swiss pharma giant is initiating a share-buyback program of up to $2.5 billion that is expected to be carried out over the next few months.

November 24, 2020
·
4 min read
·
Alex Keown
Biotech Bay

Biopharma Money on the Move: November 18-24

Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.

November 24, 2020
·
6 min read
·
Kate Goodwin
Drug Development

Widespread Vaccine Uptake Will Likely Require Full Transparency on Side Effects

Physicians are worried that a lack of transparency about side effects might prevent people from going back for a second dose, or even getting the first one.

November 24, 2020
·
3 min read
·
Heather McKenzie
Business

Thermo Fisher to Offer Routine COVID-19 Testing for Employees

As of late, the company has already tested almost 15,000 of its 75,000 employees in a pilot program.

November 24, 2020
·
2 min read
·
Krystle Vermes
BioCapital

Antitrust Panel Sets Sights on Big Pharma for Next Target

Following a year-long probe into tech giants Amazon, Apple, Facebook, and Google, the House Judiciary antitrust subcommittee has its next target in its sights – big pharma.

November 24, 2020
·
3 min read
·
Kate Goodwin
BioCapital

New Class of Drugs Harnesses Gold Nanocrystals to Heal and Protect the Brain

Clene Nanomedicine is trying to set a new “gold standard” in neurodegenerative diseases through the development of a new class of drugs called bioenergetic nanotherapeutics that harnesses the properties of gold nanocrystals.

November 24, 2020
·
4 min read
·
Alex Keown
From Acne to Cancer, BiomX Infects Bad Bacteria with Modified Viruses

While many microbiome therapies rely on adding bacteria, like probiotics, Israel-based BiomX takes a somewhat unique approach of removing harmful bacteria.

November 24, 2020
·
4 min read
·
Gail Dutton
FDA

FDA Approves Flu Treatment for Preventative Use After Exposure

Genentech’s influenza treatment Xofluza® (baloxavir marboxil) has been granted approval by the U.S. Food and Drug Administration for use in people 12 years and older, making it the first single-dose post-exposure prophylaxis strategy approved by the agency.

November 24, 2020
·
3 min read
·
Brandon May